Liposome-entrapped topoisomerase inhibitors

Details Liposome-entrapped topoisomerase inhibitors Liposome-entrapped topoisomerase inhibitors

2007-10-09

2007-10-09

Kishore, Gollamudi S. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

Reexamination Certificate

active

10962246

ABSTRACT:
A composition for administration of a therapeutically effective dose of a topoisomerase inhibitor I or topoisomerase I/II inhibitor is described. The composition includes liposomes having an outer surface and an inner surface defining an aqueous liposome compartment, and being composed of a vesicle-forming lipid and of a vesicle-forming lipid derivatized with a hydrophilic polymer to form a coating of hydrophilic polymer chains on both the inner and outer surfaces of the liposomes. Entrapped in the liposomes is the topoisomerase inhibitor at a concentration of at least about 0.10 μmole drug per μmole lipid.

REFERENCES:
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5192549 (1993-03-01), Barenolz et al.
patent: 5213804 (1993-05-01), Martin et al.
patent: 5224903 (1993-07-01), Langhof et al.
patent: 5395619 (1995-03-01), Zalipsky et al.
patent: 5552156 (1996-09-01), Burke
patent: 5631018 (1997-05-01), Zalipsky et al.
patent: 5891468 (1999-04-01), Martin
patent: 6056973 (2000-05-01), Allen et al.
patent: 6110491 (2000-08-01), Kirpotin
patent: 6355268 (2002-03-01), Slater et al.
patent: 6465008 (2002-10-01), Slater et al.
patent: WO 86/01102 (1986-02-01), None
patent: WO94/26253 (1994-11-01), None
patent: WO95/08986 (1995-04-01), None
patent: WO 98/07409 (1998-02-01), None
patent: WO98/17256 (1998-04-01), None
patent: WO 98/18450 (1998-05-01), None
patent: WO 99/13816 (1999-03-01), None
Clements, M.K., et al.,Anti-Cancer Drugs 7:851-857 (1996).
Daoud, S.S., et al.,Anti-Cancer Drugs 6:83-93 (1995).
Emerson, D.L., et al.,Proc. American Assoc. Cancer Research 39:278 (1998) (abstract #1897).
Lundberg, B.B.,Anti-Cancer Drug Design 13:453-461 (1998).
Lynam, E., et al.,Proc. American Assoc. Cance Research 39:421 (1998) (abstract #2863).
Madden, T.D., et al., “Encapsulation of topotecan in lipid-based carrier systems. Evaluation of drug stability and plasma elimination in a murine model, and comparison of antitumor efficacy against murine L1210 and B16 tumors”Proc. of ASCO17:abstract #754 (1998).
Subramamian, D. and Muller, M.T.,Oncology Research 7(9):461-469 (1995).
Sudzuka, Y., et al., Cancer Letters 127:99-106 (1998).
Zhu, G., et al.,Cancer Chemother Pharmacol 39:138-142 (1996).
Bridewell, D. et al.,Oncology Research, 9:535-542, (1997).
Burke, et al.,J. Pharmaceutical Sciences,83(7):967-969, (1994).
Burke, et al.,Biochemistry, 32(2):5352-5364, (1993).
Deamer, D.W., et al.,Biochim. Biophys. Acta, 274, 323-335, (1972).
Kanzawa, F., et al.,Cancer Res.,55(13):2806-2813, (1995).
Katzung, B., “Basic and Clinical Pharmacology”, 7thEd., (Appleton & Lang, Stamford, CT) p. 882, (1989).
Kunimoto, T., et al.,J. Pharmacobio-Dyn., 10(3):148:151, (1987).
Riou, J. F., et al.,Mol. Pharmacol., 40(5):699-706, (1991).
Rothenberg, M.L., et al.,Ann. Oncol., 8(9):837-855, (1997).
Sawanda, S., et al.,Chem. Pharm. Bull., 41(2):310-313, (1993).
Stewart, C.F. and Ratain, M.J., Topoisomerase Interactive Agents, from Chapter 19: Pharmacology of Cancer Chemotherapy, inCancer: Priciples and Practice of Oncology, 6thEdition, Lippincott Williams & Wilkins, Philidelphia, PA, Section 6, pp. 1-35, (2001).
Szoka., F., et al.,Ann. Rev. Biophys. Bioeng., 9:467, (1980).
Utsugi, T., et al.,Jpn. J. Cancer Res., 88(10):992-1002, (1997).
Wall, M.E., et al.,J. Am. Chem. Soc., 94:388, (1966).
Wasserman, K., et al.,Molecular Pharmacology, 38:38-45 (1990).
Zamboni, E., et al.,Cancer Chemother. Pharmacol., 53:329-336, (2004).

Affiliated with

Also associated with

Rating

Liposome-entrapped topoisomerase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liposome-entrapped topoisomerase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposome-entrapped topoisomerase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3903481